ADVIA CENTAUR® CKMB - COFEPRIS Registration 1425R2019 SSA
Access comprehensive regulatory information for ADVIA CENTAUR® CKMB (ADVIA CENTAUR® CKMB) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1425R2019 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.. The device was registered on July 24, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
REACTIVO PARA USO COMO DIAGNÓSTICO IN VITRO EN LA DETERMINACIÓN CUANTITATIVA DE CK-MB EN SUERO O EN PLASMA HEPARINIZADO CON LOS SISTEMAS ADVIA CENTAUR.
REAGENT FOR USE AS IN VITRO DIAGNOSTICS IN THE QUANTITATIVE DETERMINATION OF CK-MB IN SERUM OR HEPARINIZED PLASMA WITH ADVIA CENTAUR SYSTEMS.